Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
30.79
-0.11 (-0.36%)
At close: Mar 9, 2026

Vcanbio Cell & Gene Engineering Corp., Company Description

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People’s Republic of China.

It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells, and dental stem cells.

The company also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products.

In addition, it is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices.

The company was founded in 1992 and is based in Tianjin, the People’s Republic of China.

Vcanbio Cell & Gene Engineering Corp., Ltd
Country China
Founded 1992
Industry Biotechnology
Sector Healthcare
Employees 2,014
CEO Hongqi Wang

Contact Details

Address:
Huayuan Industrial Zone
Tianjin, 300384
China
Phone 86 22 5877 5766
Website vcanbio.com

Stock Details

Ticker Symbol 600645
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000000545
SIC Code 2836

Key Executives

Name Position
Hongqi Wang Vice Chairman and GM
Yi Qing Chen Deputy GM, Chief Financial Officer and Secretary
Hong Xiang Shi Deputy General Manager
Yu Zhang R&D Director
Dr. Huang Jiaxue Chief Technical Quality Officer
Yueming Wang Chief Human Resources Officer